Phage therapy is reaching an important turning point. As antimicrobial resistance (AMR)
continues to rise, and antibiotics become less effective, the world is urgently looking for new,
patient-focused treatments. Bacteriophages, viruses that specifically target and kill bacteria
, are quickly emerging as one of the most promising options.
What the phage field needs most today is a deeper global connection, stronger collaboration,
and a shared roadmap for turning scientific progress into real-world therapies.
And that is exactly what the JAFRAL Phage Summit 2026 will deliver.
A Global Meeting Shaping the Future of Phage Therapy
From clinicians, pharmacists and infectious disease specialists to biotech innovators,
regulatory authorities, industry leaders and researchers, this summit brings together every key
Stakeholder driving the next era of phage therapy.
Over three intensive days, participants will explore new developments, share clinical
experiences, and accelerate the translation of phage science into safe, effective and accessible
therapies for patients worldwide.
This is more than a conference — it’s a collective step toward redefining how we treat
bacterial infections.
What You Can Expect
Participants will have the opportunity to:
Learn from real-world clinical experiences and compassionateuse cases
Gain insights into active clinical trials and emerging outcomes
Join cross-disciplinary discussions that spark new collaborations
Discover how innovations are moving from lab to clinic
Connect with a global network dedicated to advancing patient care
Engage with regulatory experts to gain clear insights into evolving pathways for
safely advancing phage therapies.
Who Should Attend
This summit is ideal for:
Pharma & biotech professionals
Medical doctors, clinicians & infectious disease specialists
Regulatory authorities & policymakers
Hospital, clinical & community pharmacists
Researchers & translational scientists
Healthcare organizations & hospital networks
Industry partners
Academic, public health & AMR educators
Students and early-career professionals eager to join the field
Whether you’re a seasoned expert or just entering the field, you’ll find valuable opportunities
to learn, collaborate and contribute to meaningful progress.
Program Highlights
Day 1 – Global Infectious Disease Landscape & Phage Therapy
The global AMR challenge
EU policy, regulation & innovation
Insights from infectious disease specialists
Phage therapy as a global health solution
Day 2 – Clinical Trials & Current Results
Latest outcomes from completed trials
Updates from ongoing studies
Regulatory guidance shaping clinical development
Breakthroughs from biotech innovators
Day 3 – Compassionate Use & Magistral Preparations
Practical approaches to personalised phage therapy
Case studies & patient journeys
Compassionateuse regulations
Real-world hospital experiences
Speakers & Expert Lineup
The summit features leaders from top global institutions across three themed days:
Day 1 – AMR Strategy, Global Policy & Phage Therapy
Dr. Rob Lavigne, KU Leuven
Dr Jochem Spoor, Erasmus Medical Centre
Dr Tobi Nagel, Phages for Global Health
Dr Zuzanna Kazmierczak, Hirszfeld Institute
Mr Anthony Rodiadis, European Commission
Mr Pietro Erba, European Commission
Ms Tine Rikke Jørgensen, Former WHO AMR Innovation / The Globe Institute
Day 2 – Clinical Evidence: Trials, Results & Impact
Dr Christian Grøndahl, SNIPR Biome
Dr Radu Botgros, EMA
Dr Alexander Sulakvelidze, Intralytix
Dr Shawna McCallin, Balgrist University Hospital
Dr Minmin Yen, PhagePro
Dr Carmen Coxon, MHRA
Ms Amanda Burkardt, Phiogen Pharma
Dr Sofia CorteReal, Technophage
Day 3 – From Compassionate Use to Practice: RealWorld Outcomes & Patient Impact
Dr Saima Aslam, UC San Diego Health
Ms Karen Northshield, phage therapy patient
Dr. Anja Düchtling, BfArM
Dr Mark Sutton, UK Health Security Agency
Dr Silvia Würstle, Frankfurt University Hospital
Dr Andrej Trampuž, Centre for Immunology and Infection Control
Dr JeanPaul Pirnay, Queen Astrid Military Hospital
Dr. Kārlis Rācenis, Rīga Stradiņš University
Dr. Steffen Lanwald, BG Klinikum Bergmannstrost Halle
Why This Summit Matters?
2026 marks a turning point for phage therapy:
More clinical evidence is emerging, giving the field stronger data and clearer
direction.
Regulatory agencies are increasingly engaged, helping shape practical pathways for
future therapies.
Hospitals and healthcare systems are showing growing interest, driven by real patient
needs and rising AMR.
Biotech and pharma investment is expanding, accelerating innovation and
development.
Global collaboration on AMR is strengthening, uniting experts across sectors and
regions.
The JAFRAL Phage Summit 2026 brings all these forces into one place — creating
momentum toward a future where phage therapy becomes a safe, accessible and routine
option for patients who need it most.
Poster Submissions
Poster submissions are open to researchers, clinicians, students and professionals interested in
presenting their work to the global phage community. Projects, case studies and innovative
concepts across all areas of phage science and application are welcome.
Details and submission guidelines are available at: Jafral
The phage blog is glad to be a media partner for the JAFRAL Phage Summit 2026. If you’re planning to attend, you can use promo code THEPHAGEBLOG5 for 5% off registration (this does not apply to student registrations, as their fee is already significantly reduced).